EUVIMEDEUVIMED entdecken
Open Access

Advanced cardiac organoid model for studying doxorubicin-induced cardiotoxicity

Xian Wu iD, Savanna Williams, Jacques Robidoux, Srinivas Sriramula iD, Abdel Abdel-Rahman

Toxicological Sciences · 01.11.2025 · 208 (1) · 95-103

DOI: 10.1093/toxsci/kfaf115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 12.08.2025. Verfasst von Xian Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Brody School of Medicine at East Carolina University, Greenville, NC 27834, United States. Hauptthemen laut MEDLINE: Doxorubicin, Organoids, Myocytes, Cardiac, Cardiotoxicity. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Pharmacology & Toxicology New Faculty Start-Up Funds in Brody School of Medicine East Carolina University, NIEHS NIH HHS, NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac organoids provide an in vitro platform for studying heart disease mechanisms and drug responses. However, a major limitation is the immaturity of cardiomyocytes, restricting their ability to mimic adult cardiac physiology. Additionally, the inadequacy of commonly used extracellular matrices (ECMs), which fail to replicate the biochemical and mechanical properties of natural heart tissue, poses significant challenges. Consequently, structural integrity in cardiac organoids is impaired. Moreover, scalability remains an obstacle, as conventional ECM substitutes hinder mass production of organoids for high-throughput toxicology screening. To overcome these challenges, we developed an advanced model promoting fibroblast-driven ECM self-secretion, enabling physiologically relevant tissue architecture and function. Using the ECM-free, mature cardiomyocyte-integrated organoid model, we investigated the cardiotoxicity of doxorubicin, a widely used chemotherapeutic agent known to impair cardiac function. Cardiomyocytes derived from induced pluripotent stem cells were characterized for maturity by immunostaining for cardiac troponin T and myosin regulatory light chain 2 alongside gene expression analysis. Organoids treated with doxorubicin showed reduced size and increased collagen deposition. These structural changes correlated with functional impairments, including decreased beating rate and disrupted synchronous beating. In 2D culture, exposure to doxorubicin induced fibroblast activation, promoted early molecular signatures of endothelial-to-mesenchymal transition in endothelial cells, and triggered cytotoxic effects in cardiomyocytes. This study highlights the importance of ECM remodeling in advancing cardiac organoid models and demonstrates its potential for more accurate cardiotoxicity assessment. Addressing these limitations enhances the physiological relevance of cardiac organoid systems for drug safety assessment and cardiac disease modeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinOrganoidsMyocytes, CardiacCardiotoxicityAntibiotics, AntineoplasticHumansFibroblastsExtracellular MatrixInduced Pluripotent Stem CellsMyosin Light ChainsAnimalsTroponin T

Stichwörter der Autor:innen

cardiac organoidcardiotoxicitychemotherapypluripotent stem cells

Substanzen

DoxorubicinAntibiotics, AntineoplasticMyosin Light ChainsTroponin T

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Brody School of Medicine at East Carolina University, Greenville, NC 27834, United States.

ORCID-Profile: Xian Wu, Srinivas Sriramula

Förderung

  • Pharmacology & Toxicology New Faculty Start-Up Funds in Brody School of Medicine East Carolina University
  • NIEHS NIH HHS
  • NIAAA NIH HHS
  • NIH HHS
  • National Institute of Environmental Health Sciences
  • National Institutes of Health
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Wu, X., Williams, S., Robidoux, J., Sriramula, S., & Abdel-Rahman, A. (2025). Advanced cardiac organoid model for studying doxorubicin-induced cardiotoxicity. Toxicological Sciences, 208(1), 95-103. https://doi.org/10.1093/toxsci/kfaf115

Vancouver

Wu X, Williams S, Robidoux J, Sriramula S, Abdel-Rahman A. Advanced cardiac organoid model for studying doxorubicin-induced cardiotoxicity. Toxicological Sciences. 2025;208(1):95-103. doi:10.1093/toxsci/kfaf115

BibTeX
@article{Wu2025,
  author = {Wu, Xian and Williams, Savanna and Robidoux, Jacques and Sriramula, Srinivas and Abdel-Rahman, Abdel},
  title = {Advanced cardiac organoid model for studying doxorubicin-induced cardiotoxicity},
  journal = {Toxicological Sciences},
  year = {2025},
  volume = {208},
  number = {1},
  pages = {95--103},
  doi = {10.1093/toxsci/kfaf115}
}
Kostenlos starten →